Literature DB >> 10933193

Cord blood transplantation and cord blood bank in Japan.

S Kato1, H Nishihira, H Hara, K Kato, T Takahashi, N Sato, Y Kodera, H Saito, H Sato, M Takanashi.   

Abstract

The first cord blood transplantation (CBT) was performed in a 5-year-old boy with acute myelogenous leukemia from his HLA-identical sibling donor in 1994. Since then there have been 17 related and 131 unrelated CBTs in Japan. Overall survival and disease-free survival (DFS) were over 70% in sibling donor CBT. DFS of unrelated CBT in leukemia and other hematological malignancies was 43%, and OS of UCBT in non-malignant diseases was 63%. HLA disparity between the donor and the recipient did not affect the incidence and severity of acute graft-versus-host disease (GVHD) or survival. Cell dose was the most important factor for engraftment and survival both in malignant and in non-malignant diseases. The Japanese government has recently established the nationwide cord blood bank network, and eight local cord blood banks are financially supported by the government. 20,000 units of CB are planned to be collected and stored in the next 5 years by this network.

Entities:  

Mesh:

Year:  2000        PMID: 10933193     DOI: 10.1038/sj.bmt.1702358

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  2 in total

1.  Second transplantation with CD34+ blood cells from an HLA-mismatched related donor after engraftment failure of transplanted cord blood cells.

Authors:  H Ohta; J Y Kim; A Sawada; S Tokimasa; H Fujisaki; Y Matsuda; Y Osugi; J Hara
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

2.  Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation.

Authors:  Yasuo Morishima; Fumihiro Azuma; Koichi Kashiwase; Kayoko Matsumoto; Takeshi Orihara; Hiromasa Yabe; Shunichi Kato; Koji Kato; Shunro Kai; Tetsuo Mori; Kazunori Nakajima; Satoko Morishima; Masahiro Satake; Minoko Takanashi; Toshio Yabe
Journal:  Stem Cells Transl Med       Date:  2017-12-23       Impact factor: 6.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.